Provider's Claims for COVID-19 Screening Charges Move Forward
Free Article Limit This Month
- A district court in Texas has found that a provider may proceed with its lawsuit to recover the full amount of its charges for COVID-19 diagnostic testing under the FFCRA and CARES Act from an insurer.
Addressing motions to dismiss, a district court in Texas has found that a provider may proceed with its lawsuit to recover the full amount of its charges for COVID-19 diagnostic testing under the FFCRA and CARES Act from an insurer.
The FFCRA and CARES Act require health plans and insurers to pay the amount published by a provider for such screenings without cost-sharing by a plan participant and without the application of prior approval or other medical management procedures. In this case, the provider published its charge, which was $900 per diagnostic screening.
The court dismissed some counts, but found, most significantly, that the FFCRA and CARES Act afford providers a private right of action to recover their charges for COVID-19 screenings. While allowing the civil action to proceed, the court left the door open for certain claims to be challenged, where the provider failed to obtain a proper assignment of a participant's claim. Some plans or policies may include a clause prohibiting assignment, but that issue did not arise in this decision.
ALM expressly disclaims any express or implied warranty regarding the OnPractice Content, including any implied warranty that the OnPractice Content is accurate, has been corrected or is otherwise free from errors.